ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression

Cardiovascular Research

Volumn 93, Issue 1, 2012, Pages 111-119

  Mannell, Hanna K ^a   Pircher, Joachim ^a   Chaudhry, Daniel I ^a   Alig, Stefan K C ^a   Koch, Elisabeth G ^a   Mettler, Ramona ^a   Pohl, Ulrich ^a   Krtz, Florian ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Angiogenesis; ARNO; Cytohesin 2; Endothelial cells; VEGFR 2

Indexed keywords

ADP RIBOSYLATION FACTOR NUCLEOTIDE BINDING SITE OPENER; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CREMASTER MUSCLE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CAPILLARY PERMEABILITY; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; GTPASE-ACTIVATING PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84555188582     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr265     Document Type: Article

References (37)

1. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777-794. (Pubitemid 43116546)
2. Breslin JW, Pappas PJ, Cerveira JJ, Hobson RW II, Duran WN. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Heart Circ Physiol 2003;284:H92-H100. (Pubitemid 36076274)
3. Abid M, Guo S, Minami T, Spokes KC, Ueki K, Skurk C et al. Vascular endothelial growth factor activates PI3K/Akt/Forkhead signaling in endothelial cells. Arter Throm Vasc Biol 2004;24:294-300. (Pubitemid 38197581)
4. Distler O, Neidhart M, Gay RE, Gay S. The molecular control of angiogenesis. Int Rev Immunol 2002;21:33-49. (Pubitemid 34718259)
5. Distler JH, Hirth A, Kurowska S, Gay RE, Gay S, Distler O. Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 2003;47:149-161. (Pubitemid 37279152)
6. Thompson JE, Thompson CB. Putting the Rap on Akt. J Clin Oncol 2004;22: 4217-4226. (Pubitemid 41185193)
7. Wu S, Guo W, Fang B. Development of small-molecule inhibitors of Raf. Recent Pat Antiinfect Drug Discov 2006;1:241-246.
8. Domin J, Waterfield MD. Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett 1997;410:91-95. (Pubitemid 27283391)
9. Venkateswarlu K, Oatey P, Tavare J, Cullen P. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr Biol 1998;8:463-466. (Pubitemid 28181124)
10. D'Souza-Schorey C, Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006;7:347-358.
11. Casanova JE. Regulation of Arf activation: the Sec7 family of guanine nucleotide exchange factors. Traffic 2007;8:1476-1485. (Pubitemid 47578354)
12. Ikeda S, Ushio-Fukai M, Zuo L, Tojo T, Dikalov S, Patrushev NA et al. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 2005;96:467-475. (Pubitemid 40354541)
13. Fuss B, Becker T, Zinke I, Hoch M. The cytohesin Steppke is essential for insulin signalling in Drosophila. Nature 2006;444:945-948. (Pubitemid 46025009)
14. Maiese K, Chong ZZ, Shang YC, Hou J. FoxO proteins: cunning concepts and considerations for the cardiovascular system. Clin Sci (Lond) 2009;116:191-203.
15. Krotz F, Sohn HY, Gloe T, Plank C, Pohl U. Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res 2003;40:425-434. (Pubitemid 37465090)
16. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992;99:683-690. (Pubitemid 23002027)
17. Mannell H, Hellwig N, Gloe T, Plank C, Sohn HY, Groesser L et al. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. J Vasc Res 2008;45:153-163. (Pubitemid 351651301)
18. Krotz F, de Wit C, Sohn HY, Zahler S, Gloe T, Pohl U et al. Magnetofection-a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003;7: 700-710. (Pubitemid 36626250)
19. Krotz F, Engelbrecht B, Buerkle MA, Bassermann F, Bridell H, Gloe T et al. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J Am Coll Cardiol 2005;45:1700-1706. (Pubitemid 40704509)
20. Chen J, Chen L, Wang G, Tang H. Cholesterol-dependent and-independent CD40 internalization and signaling activation in cardiovascular endothelial cells. Arter Throm Vasc Biol 2007;27:2005-2013. (Pubitemid 47312311)
21. Hsu SM. Immunohistochemistry. Methods Enzymol 1990;184:357-363.
22. Mannell H, Hammitzsch A, Mettler R, Pohl U, Krotz F. Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt. Cell Signal 2010;22:88-96.
23. Struthmann L, Hellwig N, Pircher J, Sohn HY, Buerkle MA, Klauss V et al. Prothrombotic effects of diclofenac on arteriolar platelet activation and thrombosis in vivo. J Thromb Haemost 2009;7:1727-1735.
24. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 1973;5:384-394.
25. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001;7:575-583. (Pubitemid 32448325)
26. Mitola S, Brenchio B, Piccinini M, Tertoolen L, Zammataro L, Breier G et al. Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. Circ Res 2006;98:45-54. (Pubitemid 43970202)
27. Hafner M, Schmitz A, Grune I, Srivatsan SG, Paul B, Kolanus W et al. Inhibition of cytohesins by SecinH3 leads to hepatic insulin resistance. Nature 2006;444:941-944. (Pubitemid 46025008)
28. Oh SJ, Santy LC. Differential Effects of Cytohesins 2 and 3 on beta1 Integrin Recycling. J Biol Chem 2010;285:14610-14616.
29. Santy LC, Casanova JE. Activation of ARF6 by ARNO stimulates epithelial cell migration through downstream activation of both Rac1 and phospholipase D. J Cell Biol 2001;154:599-610. (Pubitemid 34286164)
30. Torii T, Miyamoto Y, Sanbe A, Nishimura K, Yamauchi J, Tanoue A. Cytohesin-2/ARNO, through its interaction with focal adhesion adaptor protein paxillin, regulates preadipocyte migration via the downstream activation of Arf6. J Biol Chem 2010;285: 24270-24281.
31. Dougher M, Terman BI. Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization. Oncogene 1999;18:1619-1627. (Pubitemid 29108062)
32. Mukherjee S, Tessema M, Wandinger-Ness A. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function. Circ Res 2006;98:743-756.
33. Feng D, Nagy JA, Brekken RA, Pettersson A, Manseau EJ, Pyne K et al. Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors. J Histochem Cytochem 2000;48:545-556.
34. Labrecque L, Royal I, Surprenant DS, Patterson C, Gingras D, Beliveau R. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol Biol Cell 2003;14:334-347. (Pubitemid 36106041)
35. Donaldson JG. Multiple roles for Arf6: sorting, structuring, and signaling at the plasma membrane. J Biol Chem 2003;278:41573-41576. (Pubitemid 37310409)
36. Frank SR, Hatfield JC, Casanova JE. Remodeling of the actin cytoskeleton is coordinately regulated by protein kinase C and the ADP-ribosylation factor nucleotide exchange factor ARNO. Mol Biol Cell 1998;9:3133-3146. (Pubitemid 28516627)
37. Li CC, Chiang TC, Wu TS, Pacheco-Rodriguez G, Moss J, Lee FJ. ARL4D recruits cytohesin-2/ARNO to modulate actin remodeling. Mol Biol Cell 2007;18:4420-4437. (Pubitemid 350060170)